Pierce Christopher 4
4 · Prelude Therapeutics Inc · Filed Sep 29, 2020
Insider Transaction Report
Form 4
Pierce Christopher
EVP and Chief of Business Oper
Transactions
- Purchase
Common Stock
2020-09-29$19.00/sh+3,750$71,250→ 3,750 total
4 · Prelude Therapeutics Inc · Filed Sep 29, 2020
Common Stock